Learn More
STEMCELL Technologies RosetteSep™ Human CD45 Depletion Cocktail, For processing: 200 mL whole blood

The RosetteSep™ Human CD45 Depletion Cocktail is designed to enrich epithelial circulating tumor cells (CTCs) from whole blood by depleting CD45+ cells. Unwanted cells are targeted for depletion with Tetrameric Antibody Complexes recognizing CD45, CD66b and glycophorin A on red blood cells (RBCs). When centrifuged over a buoyant density medium such as Lymphoprep™ (Catalog #07801), the unwanted cells pellet along with the RBCs. The purified epithelial tumor cells are present as a highly enriched population at the interface between the plasma and the buoyant density medium. Products are for Research Use Only, Not for Diagnostic or Therapeutic use, and are not to be administered to humans.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.